Physician profile
William J Lawton
NPI 1679776561
$611.16
in general payments reported to CMS, 2019-2025
12 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $17.81 · 2021: $56.75 · 2022: $32.97 · 2023: $68.36 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.77 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $211.33 | 2019-2025 | Acquire |
| Abbvie INC. | $79.74 | 2019-2023 | |
| Amgen INC. | $72.95 | 2025 | Uplizna |
| Janssen Biotech, INC. | $63.88 | 2021-2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $50.61 | 2019-2025 | Eohilia |
| Celgene Corporation | $35.36 | 2023 | Zeposia |
| Madrigal Pharmaceuticals | $21.55 | 2025 | Rezdiffra |
| Intercept Pharmaceuticals, INC. | $16.29 | 2025 | |
| Nestle Healthcare Nutrition INC. | $16.11 | 2023 | |
| Ferring Pharmaceuticals INC. | $16.06 | 2022 | |
| Merck Sharp & Dohme LLC | $15.54 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lawton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.